These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 25435994

  • 1. Salivary duct carcinoma of the parotid gland: A case report and review of the literature.
    Xie S, Yang H, Bredell M, Shen S, Yang H, Jin L, Zhang S.
    Oncol Lett; 2015 Jan; 9(1):371-374. PubMed ID: 25435994
    [Abstract] [Full Text] [Related]

  • 2. Intraoral salivary duct carcinoma: A case report and a brief review.
    Acharya S, Padmini S, Koneru A, Krishnapillai R.
    J Oral Maxillofac Pathol; 2014 Sep; 18(Suppl 1):S121-7. PubMed ID: 25364161
    [Abstract] [Full Text] [Related]

  • 3. Salivary Duct Carcinoma and Invasive Ductal Carcinoma of the Breast: A Comparative Immunohistochemical Study.
    Jalaly JB, Sanati S, Chernock RD, Dibe DG, El-Mofty SK.
    Head Neck Pathol; 2018 Dec; 12(4):488-492. PubMed ID: 29302899
    [Abstract] [Full Text] [Related]

  • 4. Low-grade salivary duct carcinoma of the parotid gland: report of a case with immunohistochemical analysis.
    Kusafuka K, Itoh H, Sugiyama C, Nakajima T.
    Med Mol Morphol; 2010 Sep; 43(3):178-84. PubMed ID: 20857268
    [Abstract] [Full Text] [Related]

  • 5. Denovo High Grade Salivary Duct Carcinoma: A Case Report and Review of Literature.
    Zainab H, Sultana A, Jahagirdar P.
    J Clin Diagn Res; 2017 Jul; 11(7):ZD10-ZD12. PubMed ID: 28893053
    [Abstract] [Full Text] [Related]

  • 6. Clinicopathological features and treatment outcomes of the rare, salivary duct carcinoma of parotid gland.
    Al-Qahtani KH, Tunio MA, Bayoumi Y, Gurusamy VM, Bahamdain FA, Fatani H.
    J Otolaryngol Head Neck Surg; 2016 May 16; 45(1):32. PubMed ID: 27184361
    [Abstract] [Full Text] [Related]

  • 7. Clinicopathological and immunohistochemical behavior of ductal carcinoma of the salivary and lacrimal gland in a Mexican Mestizo population.
    Luna-Ortiz K, Dominguez-Malagon H, Corredor-Alonso GE, Reynoso-Noveron N, Herrera-Ponzanelli C, Luna-Peteuil Z, Zacarias-Ramon LC.
    Eur Arch Otorhinolaryngol; 2022 Jan 16; 279(1):327-333. PubMed ID: 33763743
    [Abstract] [Full Text] [Related]

  • 8. Adjuvant Treatment of the Salivary Duct Carcinoma with Her2 Overexpression.
    Berendika J, Jungić S, Tubić B, Malčić Kecman G, Rakita I, Gojković Z, Vještica M, Nikić G, Babić B.
    Case Rep Oncol; 2021 Jan 16; 14(1):610-615. PubMed ID: 33976642
    [Abstract] [Full Text] [Related]

  • 9. Salivary duct carcinoma of the parotid gland: is adjuvant HER-2-targeted therapy required?
    Lee JS, Kwon OJ, Park JJ, Seo JH.
    J Oral Maxillofac Surg; 2014 May 16; 72(5):1023-31. PubMed ID: 24480767
    [Abstract] [Full Text] [Related]

  • 10. HER2/neu negative salivary duct carcinoma of parotid: A case with forty months recurrence free follow up.
    Gokavarapu S, Fonseca D, Puthamakula S, Reddy BP, Reddy BS, Murthy S.
    Int J Surg Case Rep; 2015 May 16; 8C():22-4. PubMed ID: 25603487
    [Abstract] [Full Text] [Related]

  • 11. Salivary Duct Carcinoma with Rhabdoid Features of the Parotid Gland with No E-Cadherin Expression: A Report with Anti-HER2 Therapy and Review of the Literature.
    Jain R, Sansoni ER, Angel J, Gleysteen JP, Hayes DN, Owosho AA.
    Dent J (Basel); 2023 Sep 25; 11(10):. PubMed ID: 37886914
    [Abstract] [Full Text] [Related]

  • 12. Salivary duct carcinoma: diagnostic clues, histology and treatment.
    Pont E, Plá Á, Cruz Mojarrieta J, Ferrandis E, Brotons S, Vendrell JB.
    Acta Otorrinolaringol Esp; 2013 Sep 25; 64(2):150-3. PubMed ID: 22153962
    [Abstract] [Full Text] [Related]

  • 13. Salivary Duct Carcinoma with Late Distant Brain and Cutaneous Metastasis: A Case Report.
    Mirmohammad Sadeghi H, Karimi A, Rahpeima A, Derakhshan S.
    Iran J Pathol; 2020 Sep 25; 15(3):521-525. PubMed ID: 32754223
    [Abstract] [Full Text] [Related]

  • 14. Salivary duct carcinoma: A clinopathological report of 11 cases.
    Huang X, Hao J, Chen S, Deng R.
    Oncol Lett; 2015 Jul 25; 10(1):337-341. PubMed ID: 26171026
    [Abstract] [Full Text] [Related]

  • 15. Salivary duct carcinoma: a clinical and histologic review with implications for trastuzumab therapy.
    Nabili V, Tan JW, Bhuta S, Sercarz JA, Head CS.
    Head Neck; 2007 Oct 25; 29(10):907-12. PubMed ID: 17563907
    [Abstract] [Full Text] [Related]

  • 16. Androgen Deprivation Therapy for Patients with Androgen-Receptor-Positive Metastatic Salivary Duct Carcinoma: A Case Report and Review of the Literature.
    You Y, Wang P, Wan X, Xu L, Gong Y, Zhang W.
    Onco Targets Ther; 2021 Oct 25; 14():3481-3486. PubMed ID: 34093024
    [Abstract] [Full Text] [Related]

  • 17. Salivary duct carcinoma responding to trastuzumab-based therapy: case report and review of the literature.
    Krishnamurthy J, Krishnamurty DM, Baker JJ, Zhen W, Lydiatt D, Ganti AK.
    Head Neck; 2013 Dec 25; 35(12):E372-5. PubMed ID: 23765450
    [Abstract] [Full Text] [Related]

  • 18. Salivary duct carcinoma with rhabdoid features: a salivary counterpart of pleomorphic lobular carcinoma of the breast.
    Kusafuka K, Kawasaki T, Maeda M, Yamanegi K, Baba S, Ito Y, Inagaki H, Nakajima T.
    Histopathology; 2017 Jan 25; 70(2):164-173. PubMed ID: 27079821
    [Abstract] [Full Text] [Related]

  • 19. Sarcomatoid salivary duct carcinoma of the parotid gland.
    Henley JD, Seo IS, Dayan D, Gnepp DR.
    Hum Pathol; 2000 Feb 25; 31(2):208-13. PubMed ID: 10685635
    [Abstract] [Full Text] [Related]

  • 20. Salivary Duct Carcinoma: An Aggressive Salivary Gland Carcinoma with Morphologic Variants, Newly Identified Molecular Characteristics, and Emerging Treatment Modalities.
    Rahman M, Griffith CC.
    Surg Pathol Clin; 2021 Mar 25; 14(1):111-126. PubMed ID: 33526216
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.